Nonmetabolic complications of continuous subcutaneous insulin infusion: A patient survey

Diabetes Technology and Therapeutics

Volumn 16, Issue 3, 2014, Pages 145-149

  Pickup, John C ^a   Yemane, Nardos ^b   Brackenridge, Anna ^b   Pender, Siobhan ^b  

^a GUY S HOSPITAL   (United Kingdom)

^b GUY'S AND ST THOMAS' NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

INSULIN ASPART; INSULIN GLULISINE; INSULIN LISPRO; POLITEF; ANTIDIABETIC AGENT; INSULIN;

ADULT; ARTICLE; CANNULA; COMPLICATION; CONTINUOUS INFUSION; HUMAN; INFUSION SET BLOCKAGE; INFUSION SET FREQUENT BLOCKAGE; INFUSION SET FREQUENT KINKING; INFUSION SET KINKING; INFUSION SET LEAKAGE; INFUSION SITE ADHESION PROBLEM; INFUSION SITE BLEEDING; INFUSION SITE BRUISING; INFUSION SITE INFECTION; INFUSION SITE IRRITATION; INFUSION SITE ITCHING; INFUSION SITE PAIN; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN INFUSION; INSULIN PUMP; LIPOHYPERTROPHY; MAJOR CLINICAL STUDY; MIDDLE AGED; PRIORITY JOURNAL; RISK ASSESSMENT; TREATMENT DURATION; WEIGHT GAIN; WEIGHT REDUCTION; ADIPOSE TISSUE; DIABETES MELLITUS, TYPE 1; FEMALE; HEALTH CARE SURVEY; HYPERTROPHY; MALE; PREVALENCE; QUESTIONNAIRE; RISK; RISK FACTOR; SELF REPORT; SUBCUTANEOUS DRUG ADMINISTRATION; TREATMENT OUTCOME;

ADIPOSE TISSUE; ADULT; DIABETES MELLITUS, TYPE 1; FEMALE; HEALTH CARE SURVEYS; HUMANS; HYPERTROPHY; HYPOGLYCEMIC AGENTS; INJECTIONS, SUBCUTANEOUS; INSULIN; INSULIN INFUSION SYSTEMS; MALE; ODDS RATIO; PREVALENCE; QUESTIONNAIRES; RISK FACTORS; SELF REPORT; TREATMENT OUTCOME; WEIGHT GAIN;

EID: 84896805109     PISSN: 15209156     EISSN: 15578593     Source Type: Journal    
DOI: 10.1089/dia.2013.0192     Document Type: Article

References (22)

1. Pickup JC: Insulin-pump therapy for type 1 diabetes mellitus. N Engl J Med 2012;366:1616-1624.
2. Bruttomesso D, Costa S, Baritussio A: Continuous subcutaneous insulin infusion (CSII) 30 years later: still the best option for insulin therapy. Diabet Metab Res Rev 2009;25:99-111.
3. Retnakaran R, Hochman J, DeVries JH, Hanaire-Broutin H, Heine RJ, Melki V, Zinman B: Continuous subcutaneous insulin infusion versus multiple daily injections. The impact of baseline A1c. Diabetes Care 2004;27:2590-2596.
4. Pickup JC, Sutton AJ: Severe hypoglycaemia and glycaemic control in type 1 diabetes: meta-analysis of multiple daily insulin injections versus continuous subcutaneous insulin infusion. Diabet Med 2008;25:765-774.
5. Shetty G, Wolpert H: Insulin pump use in adults with type 1 diabetes-practical issues. Diabetes Technol Ther 2010; 12(Suppl 1):11-16.
6. Scheiner G, Sobel J, Smith DE, Pick AJ, Kruger D, King J, Green K: Insulin pump therapy: guidelines to successful outcomes. Diabetes Educ 2009;35(Suppl 2):29S-41S.
7. Guilhem I, Leguerrier AM, Lecordier F, Poirier JY, Maugendre D: Technical risks with subcutaneous insulin infusion. Diabetes Metab 2006;32:279-284.
8. Mecklenburg RS, Guinn TS, Sannar CA, Blumenstein BA: Malfunction of continuous subcutaneous insulin infusion systems: a one-year prospective study of 127 patients. Diabetes Care 1986;9:351-355.
9. Guilhem I, Balkau B. Lecordier F, Malécot JM, Elbardi S, Leguerier AM, Poirier JY, Derrien C, Bonnet F: Insulin pump failures are still frequent: a prospective study over 6 years from 2001 to 2007. Diabetologia 2009;52:2662-2664.
10. Cope JU, Morrison AE, Samuels-Reid J: Adolescent use of insulin and patient-controlled analgesia pump technology: A 10-year Food and Drug Administration retrospective study of adverse events. Pediatrics 2008;121:1133-1138.
11. Conwell LS, Pope E, Artilies AM, Mohanta A, Daneman A, Daneman D: Dermatological complications of continuous subcutaneous insulin infusion in children and adolescents. J Pediatr 2008;152:622-628.
12. Kerr D, Morton J, Wately-Smith C, Everett J, Begley JP: Laboratory-based non-clinical comparison of occlusion rates using three rapid-acting insulin analogs in continuous subcutaneous insulin infusion catheters using low flow rates. J Diabetes Sci Technol 2008;2:450-455.
13. Schmid V, Hohberg C, Borchert M, Forst T, Pfützner A: Pilot study for assessment of optimal frequency for changing catheters in insulin pump therapy-trouble starts at day 3. J Diabetes Sci Technol 2010;4:976-982.
14. Thethi TK, Rao A, Kawji H, Mallik T, Yau CL, Christians U, Fonseca VJ: Consequences of delayed pump infusion line change in patients with type 1 diabetes mellitus treated with continuous subcutaneous insulin infusion. J Diabetes Complications 2010;24:73-78.
15. Bode BW: Comparison of pharmacokinetic properties, physicochemical stability, and pump compatibility of 3 rapid-acting insulin analogues-aspart, lispro and glulisine. Endocr Pract 2011;17:271-280.
16. Young RJ, Hannan WJ, Frier BM, Steel JM, Duncan LJP: Diabetic lipohypertrophy delays insulin absorption. Diabetes Care 1984;7:479-480.
17. Bruttomesso D, Pianta A, Crazzolara E, Scaldaferri E, Lorea L, Guarneri G, Mongillo A, Gennaro R, Miola M, Moretti M, Confortin L, Beltramello GP, Pais M, Baritussio A, Casiglia E, Tiengo A: Continuous subcutaneous insulin infusion (CSII) in the Veneto region: efficacy, acceptability and quality of life. Diabet Med 2002;19:628-634.
18. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin- dependent diabetes mellitus. Diabetes Control and Complications Trial Research Group. N Engl J Med 1993;329:977-986.
19. National Institute for Health and Clinical Excellence: Continuous Subcutaneous Insulin Infusion for the Treatment of Diabetes Mellitus. Technology Appraisal Guidance 151 (Review of Technology Appraisal Guidance 57). London: NICE, 2008.
20. Pickup J, ed. Insulin Pump Therapy and Continuous Glucose Monitoring. Oxford, United Kingdom: Oxford University Press, 2009.
21. Aberle I, Scholz U, Back-Kliegel B, Fischer C, Gorny M, Langer K, Kliegel M: Psychological aspects in continuous subcutaneous insulin infusion: a retrospective study. J Psychol 2009;143:147-160.
22. Phillip M, Battelino T, Rodriguez H, Danne T, Kaufman F: Use of insulin pump therapy in the pediatric age-group. Diabetes Care 2007;30:1653-1662.